Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson’s disease with clinical and neuroimaging measure

2016 Ye, Z., Rae, C.L., Nombela, C., Ham, T., Rittman, T., Jones, P.S., Vázquez Rodríguez, P., Coyle-Gilchrist, I., Regenthal, R., Altena, E., Housden, C.R., Maxwell, H., Sahakian, B.J., Barker, R.A., Robbins, T.W., Rowe, J.B.*